Artivion | CRY - Equity Capital And Reserves


Artivion reported $450.47M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Accuray USD 53.42M 8.45M Dec/2025
AngioDynamics USD 176.33M 2.52M Sep/2025
Artivion USD 450.47M 2.24M Mar/2026
AtriCure USD 516.43M 24.74M Jun/2026
Baxter International USD 6.21B 163M Jun/2026
Becton, Dickinson and Co. USD 24.13B 1.15B Mar/2026
Boston Scientific USD 24.93B 934M Jun/2026
Edwards Lifesciences USD 10.62B 290.5M Jun/2026
Inogen USD 197.18M 2.32M Sep/2025
Integra LifeSciences USD 1.04B 971K Jun/2026
J&J USD 84.97B 3.78B Jun/2026
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Orthofix International USD 435.19M 14.85M Mar/2026
Pfizer USD 85.19B 4.91B Jun/2026
ResMed USD 6.49B 171.03M Mar/2026
Stryker USD 22.98B 559M Mar/2026
Tandem Diabetes Care USD 132.4M 22.77M Mar/2026
Teleflex USD 3.08B 40.33M Mar/2026
Terumo JPY 1.58T 62.18B Mar/2026
Trinity Biotech USD -71.98M 17.26M Dec/2025